The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.

The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.

Item
http://www.wikidata.org/entity/Q34081616
Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical TrialsA five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2.Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapyThe best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective studyPrevalence of Hyponatremia in Palliative Care Patients.Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit.Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States.Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients.Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study.The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia.Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up.
P2860

The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.

Item
http://www.wikidata.org/entity/Q34081616
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The impact of low serum sodium ...... ll Cancer Database Consortium.
@ast
The impact of low serum sodium ...... ll Cancer Database Consortium.
@en
The impact of low serum sodium ...... ll Cancer Database Consortium.
@nl
type
label
The impact of low serum sodium ...... ll Cancer Database Consortium.
@ast
The impact of low serum sodium ...... ll Cancer Database Consortium.
@en
The impact of low serum sodium ...... ll Cancer Database Consortium.
@nl
prefLabel
The impact of low serum sodium ...... ll Cancer Database Consortium.
@ast
The impact of low serum sodium ...... ll Cancer Database Consortium.
@en
The impact of low serum sodium ...... ll Cancer Database Consortium.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
The impact of low serum sodium ...... ll Cancer Database Consortium.
@en
P2093
P2860
P304
P31
P356
10.1016/J.EURURO.2013.10.013
P407
P433
P478
P50
P577
P5875
P698
P932